NGVT · NYSE
Ingevity (NGVT) Stock Price & Fundamentals
Ingevity (NGVT) closed at $1,385.95 on Oct 9, 2026, up 1.50% from the previous close of $1,365.42.
Share price, past year
1Y +65.87%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,385.95 |
| Sep 30, 2026 | $1,343.45 |
| Aug 31, 2026 | $1,267.21 |
| Jul 31, 2026 | $1,200.24 |
| Jun 30, 2026 | $1,132.10 |
| May 29, 2026 | $1,085.13 |
| Apr 30, 2026 | $1,073.12 |
| Mar 31, 2026 | $1,070.19 |
| Feb 27, 2026 | $1,042.94 |
| Jan 30, 2026 | $990.35 |
| Dec 31, 2025 | $925.91 |
| Nov 28, 2025 | $924.04 |
| Oct 31, 2025 | $912.21 |
Key statistics
- Market cap
- $47.79B
- P/E (TTM)
- 917.9
- EPS (TTM)
- $1.51
- Revenue (TTM)
- $1.16B
- Net income (TTM)
- $54.00M
- Shares outstanding
- 34.5M
- Dividend yield
- —
- 52-week range
- $835.55 – $1,385.95
Ingevity's market cap is $47.79B, based on a share price of $1,385.95 and 34.5M shares outstanding as of Jun 30, 2026.
Financials
Ingevity reported revenue of $1.17B for fiscal 2025, down 2.71% from fiscal 2024.
Ingevity reported a net loss of $167.10M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.17B | −2.7% | −$167.10M | −14.3% | −$4.61 | — |
| FY2024ended Dec 31, 2024 | $1.20B | −1.3% | −$430.30M | −35.9% | −$11.85 | — |
| FY2023ended Dec 31, 2023 | $1.22B | −27.1% | −$5.40M | −0.4% | −$0.15 | — |
| FY2022ended Dec 31, 2022 | $1.67B | +19.9% | $211.60M | 12.7% | $5.50 | — |
| FY2021ended Dec 31, 2021 | $1.39B | +14.4% | $118.10M | 8.5% | $2.95 | — |
| FY2020ended Dec 31, 2020 | $1.22B | −5.9% | $181.40M | 14.9% | $4.37 | $270.30M |
| FY2019ended Dec 31, 2019 | $1.29B | +14.1% | $183.70M | 14.2% | $4.35 | $160.90M |
| FY2018ended Dec 31, 2018 | $1.13B | +16.6% | $169.10M | 14.9% | $3.97 | $158.10M |
| FY2017ended Dec 31, 2017 | $972.40M | +7.1% | $126.50M | 13.0% | $2.97 | — |
| FY2016ended Dec 31, 2016 | $908.30M | — | $35.20M | 3.9% | $0.83 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $314.10M | $35.30M | $1.00 |
| Q1 FY2026ended Mar 31, 2026 | $258.00M | $59.80M | $1.66 |
| Q4 FY2025ended Dec 31, 2025 | $255.10M | −$84.60M | −$2.33 |
| Q3 FY2025ended Sep 30, 2025 | $333.10M | $43.50M | $1.18 |
| Q2 FY2025ended Jun 30, 2025 | $331.50M | −$146.50M | −$4.02 |
| Q1 FY2025ended Mar 31, 2025 | $247.90M | $20.50M | $0.56 |
| Q4 FY2024ended Dec 31, 2024 | $135.60M | $16.60M | $0.44 |
| Q3 FY2024ended Sep 30, 2024 | $333.80M | −$107.20M | −$2.94 |
Company profile
- Name
- Ingevity Corp
- Ticker
- NGVT
- Exchange
- NYSE
- Industry (SEC SIC)
- Chemicals & Allied Products
- Headquarters
- 4920 O'Hear Avenue, Suite 400, North Charleston, SC 29405
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001653477
Recent SEC filings
- Jul 30, 2026
- Jul 29, 2026
- Jun 24, 2026
- May 7, 2026
- May 6, 2026
- May 4, 2026
- Apr 15, 2026
- Mar 30, 2026
Frequently asked questions
What is Ingevity's stock price?
Ingevity (NGVT) closed at $1,385.95 on Oct 9, 2026, up 1.50% from the previous close of $1,365.42.
What is Ingevity's market cap?
Ingevity's market cap is $47.79B, based on a share price of $1,385.95 and 34.5M shares outstanding as of Jun 30, 2026.
How much revenue does Ingevity make?
Ingevity reported revenue of $1.17B for fiscal 2025, down 2.71% from fiscal 2024.
What is NGVT's P/E ratio?
Ingevity's price-to-earnings ratio is 917.9, based on trailing twelve-month diluted EPS of $1.51.
Does Ingevity pay a dividend?
Ingevity's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Ingevity Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures